ChemPartner PharmaTech Co., Ltd. (300149.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 9.14

From 52W high−30.57%

Volume28.64M

Market capCNY 4.90B

P/E (TTM)365.2x

P/S (TTM)4.1x

Div yield—

Key dataSep 18, 2026

Open

CNY 9.14

From 52W high

−30.57%

Volume

28.64M

Market cap

CNY 4.90B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

38.4x

P/E (TTM)

365.2x

RSI (14)

48.1

MomentumView details →

1D Return

−6.55%

YTD Return

−3.24%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

365.2x

EV/EBITDA

38.4x

EV/Sales

4.1x

P/S (TTM)

4.1x

P/B (TTM)

3.8x

ProfitabilityView details →

Gross Margin

27.37%

Net Margin

−1.00%

EBITDA Margin

10.64%

ROE (TTM)

−0.89%

ROA (TTM)

−0.56%

Asset Turnover

0.56x

GrowthView details →

Revenue YoY

+14.37%

EPS YoY

+93.67%

FCF YoY

+41.06%

Revenue CAGR 3Y

−5.07%

EPS CAGR 3Y

−65.49%

EBITDA YoY

—

MomentumView details →

1D Return

−6.55%

YTD Return

−3.24%

1Y Return

−27.11%

RSI (14)

48.1

vs 50D SMA

−4.40%

vs 200D SMA

−6.86%

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

2.13x

Quick Ratio

2.09x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.14B

Net Income (TTM)

−11.39M

Op. CF (TTM)

221.72M

Latest newsMore news →

ChemPartner PharmaTech's September 2024 strategic cooperation framework agreement with Universiti Kebangsaan Malaysia and PHARMA MEDICAL SDN BHD. in drug discovery and development expired with no concrete progress and terminated automatically.5d ago

ChemPartner PharmaTech received investor research on September 15, 2026, from investors participating online in the 2026 Guangdong Province investor collective reception day event; Chairman and CEO WOO SWEE LIAN, CFO Zha Yinqun, and Board Secretary Wu Wenhua attended.6d ago

Similar companies

阿尔特300825.SZ 联检科技301115.SZ 中胤时尚300901.SZ 百诚医药301096.SZ 诺思格301333.SZ 钢研纳克300797.SZ

Latest newsMore news →

ChemPartner PharmaTech's September 2024 strategic cooperation framework agreement with Universiti Kebangsaan Malaysia and PHARMA MEDICAL SDN BHD. in drug discovery and development expired with no concrete progress and terminated automatically.5d ago ChemPartner PharmaTech received investor research on September 15, 2026, from investors participating online in the 2026 Guangdong Province investor collective reception day event; Chairman and CEO WOO SWEE LIAN, CFO Zha Yinqun, and Board Secretary Wu Wenhua attended.6d ago